Capital City Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
1,257
-33
-3% -$33.7K 0.31% 59
2026
Q1
$1.19M Sell
1,290
-44
-3% -$44.6K 0.27% 63
2025
Q4
$1.43M Sell
1,334
-190
-12% -$182K 0.32% 58
2025
Q3
$1.16M Sell
1,524
-40
-3% -$29.8K 0.28% 65
2025
Q2
$1.22M Sell
1,564
-10
-0.6% -$7.77K 0.32% 62
2025
Q1
$1.3M Buy
1,574
+776
+97% +$646K 0.36% 61
2024
Q4
$616K Sell
798
-24
-3% -$19.9K 0.15% 77
2024
Q3
$728K Buy
822
+6
+0.7% +$5.39K 0.18% 76
2024
Q2
$739K Hold
816
0.2% 75
2024
Q1
$635K Sell
816
-72
-8% -$51.2K 0.18% 79
2023
Q4
$518K Buy
888
+21
+2% +$12.3K 0.15% 82
2023
Q3
$466K Sell
867
-80
-8% -$41.2K 0.15% 84
2023
Q2
$444K Hold
947
0.14% 88
2023
Q1
$325K Buy
947
+8
+0.9% +$2.7K 0.1% 98
2022
Q4
$344K Buy
939
+85
+10% +$30.1K 0.11% 95
2022
Q3
$277K Hold
854
0.1% 101
2022
Q2
$277K Buy
+854
New +$256K 0.09% 105
2013
Q3
Sell
-1,490
Closed -$73K 156
2013
Q2
$73K Buy
+1,490
New +$81.1K 0.03% 109

Other funds holding LLY

Capital City Trust's LLY Position: Q2 2026 in Review

Capital City Trust reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $33.7K and leaving 1,257 shares worth $1.51M. The position accounts for 0.31% of the portfolio, ranked #59.

Capital City Trust first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital City Trust held 1,257 shares of Eli Lilly worth $1.51M as of Q2 2026.
  • Capital City Trust sold 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
  • Eli Lilly made up 0.31% of Capital City Trust's portfolio in Q2 2026, its #59 holding.
  • Capital City Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital City Trust's 13F filing for Q2 2026, filed 4 Aug 2026.